Key Points
- John Kao, Alignment Healthcare's CEO, sold 180,000 shares on Feb. 10 at an average price of $20.49 for a total of $3,688,200, reducing his ownership by 6.35% to 2,652,641 shares (≈$54.35M).
- ALHC shares recently traded around $20.63 with a 52-week range of $11.63–$23.87 and a market capitalization of about $4.13 billion; the company reports a negative P/E and a 200-day moving average near $17.96.
- Analysts have a consensus rating of “Moderate Buy” with an average price target of $23.32, and several firms have raised targets (e.g., Piper Sandler to $30 and TD Cowen to $25).
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 180,000 shares of the business's stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $20.49, for a total value of $3,688,200.00. Following the sale, the chief executive officer owned 2,652,641 shares of the company's stock, valued at $54,352,614.09. The trade was a 6.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Alignment Healthcare Trading Down 0.6%
Shares of ALHC stock opened at $20.63 on Wednesday. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61. The stock's fifty day moving average is $20.85 and its two-hundred day moving average is $17.96. The firm has a market capitalization of $4.13 billion, a P/E ratio of -171.92, a PEG ratio of 5.29 and a beta of 1.16.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on the stock. Piper Sandler boosted their price target on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 6th. The Goldman Sachs Group restated a "buy" rating and set a $22.00 target price on shares of Alignment Healthcare in a report on Monday, November 3rd. TD Cowen increased their price target on Alignment Healthcare from $18.50 to $25.00 and gave the company a "buy" rating in a report on Friday, January 16th. Robert W. Baird set a $28.00 price objective on Alignment Healthcare in a research report on Friday, January 30th. Finally, Barclays upped their target price on Alignment Healthcare from $13.00 to $18.00 and gave the company an "equal weight" rating in a report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $23.32.
Read Our Latest Stock Report on ALHC
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the business. TD Asset Management Inc grew its position in Alignment Healthcare by 0.3% in the fourth quarter. TD Asset Management Inc now owns 550,966 shares of the company's stock worth $10,882,000 after acquiring an additional 1,810 shares during the period. 1492 Capital Management LLC lifted its stake in shares of Alignment Healthcare by 61.8% in the 4th quarter. 1492 Capital Management LLC now owns 324,865 shares of the company's stock valued at $6,416,000 after purchasing an additional 124,143 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in shares of Alignment Healthcare by 109.1% during the 4th quarter. BNP Paribas Financial Markets now owns 275,278 shares of the company's stock worth $5,437,000 after purchasing an additional 143,656 shares during the period. Norges Bank acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth about $5,143,000. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in Alignment Healthcare by 7,684,933.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 691,653 shares of the company's stock valued at $13,660,000 after buying an additional 691,644 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
